跳至主要内容
临床试验/CTRI/2024/08/072730
CTRI/2024/08/072730招募中2 期

An Open Label Comparative Clinical Study On Virechana Karma And Patra Pinda Sweda Followed By Vishwadi Dwadashanga Kwatha In The Management Of Mamsagata Vata W.S.R. To Fibromyalgia

Self1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2024年9月11日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
78
试验地点
1
主要终点
Any change and improvement present in Mamsagata Vata symptoms of registered patients

研究概览

简要总结

Hypothesis Research Hypothesis        There is effect of Virechana Karma and Patra Pinda Sweda Vishwadi Dwadasanga Kwatha in the management of Mamsagata Vata with special reference to       FibromyalgiaNull Hypothesis    There is no effect of Virechana Karma and Patra Pinda Sweda Vishwadi Dwadasanga Kwatha in the management of   Mamsagata Vata with special reference to Fibromyalgia

Aim of study To compare the effect of Virechana Karma and Patra Pinda Sweda Followed by Viswadi Dwadashanga Kwatha in the management of Mamsagata Vata with special reference to Fibromyalgia

Objectives of study  Primary·           To evaluate the effect of Virechana Karma and Patra Pinda Sweda Followed byViswadi Dwadashanga Kwatha in the management of Mamsagata Vata with special    reference to Fibromyalgia

Secondary

To compare the effect of Virechana Karma and Patra Pinda Sweda Followed by Viswadi Dwadashanga Kwatha in the management of Mamsagata Vata with special reference to Fibromyalgia

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients with the clinical features of Mamsagata Vata Patients with the clinical features of Fibromyalgia Patients fit for Virechana Karma Chronicity less than ten years FIQ Score should be less then thirty three.

排除标准

  • Patient suffering from any chronic debilitating disease like TB Varicose vein Asthma Rheumatoid Arthritis and other chronic problems et cetera and having other serious pathology Patients suffering from systemic disorders as cardiac problem Diabetes Mellitus Hypertension more than 140mmHg Systolic pressure and diastolic pressure more than 90 mmHg Paralysis Malignancy HIV HBsAg Leprosy Pregnant women and lactating mother.

结局指标

主要结局

Any change and improvement present in Mamsagata Vata symptoms of registered patients

时间窗: 42 weeks

次要结局

  • Improvement and change present symptoms in fibromyalgia(Changes in FIBROMYALGIA IMPACT QUESTIONNAIRE)

研究者

发起方
Self
申办方类型
Other [self financer]
责任方
Principal Investigator
主要研究者

Dr GOVIND NARAYAN

Shri Krishna AYUSH University Kurukshetra Haryana 136118

研究点 (1)

Loading locations...

相似试验